Folia Biologica
Journal of Cellular and Molecular Biology, Charles University 

Crossref logo

Fol. Biol. 2004, 50, 43-57

https://doi.org/10.14712/fb2004050020043

Comparative Gene Map of Hypertriglyceridaemia

Ondřej Šeda1,2,3

1Centre de Recherche, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada
2Department of Metabolism and Diabetes, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
3Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague, Czech Republic

References

1. Abe, H., Yamada, N., Kamata, K., Kuwaki, T., Shimada, M., Osuga, J., Shionoiri, F., Yahagi, N., Kadowaki, T., Tamemoto, H., Ishibashi, S., Yazaki, Y., Makuuchi, M. (1998) Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1. J. Clin. Invest. 101, 1784-1788. <https://doi.org/10.1172/JCI1594>
2. Agarwal, A. K., Garg, A. (2002) A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy. J. Clin. Endocr. Metab. 87, 408-411.
3. Ahn, Y. I., Valdez, R., Reddy, A. P., Cole, S. A., Weiss, K. M., Ferrell, R. E. (1991) DNA polymorphisms of the apolipoprotein AI/CIII/AIV gene cluster influence plasma cholesterol and triglyceride levels in the Mayans of the Yucatan Peninsula, Mexico. Hum. Hered. 41, 281-289. <https://doi.org/10.1159/000154014>
4. Aitman, T. J., Gotoda, T., Evans, A. L., Imrie, H., Heath, K., Trembling, P., Truman, H., Wallace, C., Doré, C., Flint, J., Křen, V., Kurtz, T. W., Zídek, V., Pravenec, M., Scott J. (1997) Quantitative trait loci for cellular defects in glucose and fatty acid metabolism in hypertensive rats. Nat. Genet. 16, 197-201. <https://doi.org/10.1038/ng0697-197>
5. Aitman, T. J., Glazier, A. M., Wallace, C. A., Cooper, L. D., Norsworthy, P. J., Wahid, F. N., Al-Majali, K. M., Trembling, P. M., Mann, C. J., Shoulders, C. C., Graf, D., St.Lezin, E., Kurtz, T. W., Křen, V., Pravenec, M., Ibrahimi, A., Abumrad, N. A., Stanton, L. W., Scott, J. (1999) Identification of Cd36 (FAT) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat. Genet. 21, 76-83. <https://doi.org/10.1038/5013>
6. Anunciado, R. V., Ohno, T., Mori, M., Ishikawa, A., Tanaka, S., Horio, F., Nishimura, M., Namikawa, T. (2000) Distribution of body weight, blood insulin and lipid levels in the SMXA recombinant inbred strains and the QTL analysis. Exp. Anim. 49, 217-224. <https://doi.org/10.1538/expanim.49.217>
7. Anunciado, R. V., Nishimura, M., Mori, M., Ishikawa, A., Tanaka, S., Horio, F., Ohno, T., Namikawa, T. (2003) Quantitative trait locus analysis of serum insulin, triglyceride, total cholesterol and phospholipid levels in the (SM/J x A/J)F2 mice. Exp. Anim. 52, 37-42. <https://doi.org/10.1538/expanim.52.37>
8. Arya, R., Blangero, J., Williams, K., Almasy, L., Dyer, T. D., Leach, R. J., O'Connell, P., Stern, M. P., Duggirala, R. (2002) Factors of insulin resistance syndrome-related phenotypes are linked to genetic locations on chromosomes 6 and 7 in nondiabetic Mexican-Americans. Diabetes 51, 841-847. <https://doi.org/10.2337/diabetes.51.3.841>
9. Austin, M. A., Talmud, P. J., Luong, L. A., Haddad, L., Day, I. N., Newman, B., Edwards, K. L., Krauss, R. M., Humphries, S. E. (1998) Candidate-gene studies of the atherogenic lipoprotein phenotype: a sib-pair linkage analysis of DZ women twins. Am. J. Hum. Genet. 62, 406-419. <https://doi.org/10.1086/301712>
10. Austin, M. A., Edwards, K. L., Monks, S. A., Koprowicz, K. M., Brunzell, J. D., Motulsky, A. G., Mahaney, M. C., Hixson, J. E. (2003) Genome-wide scan for quantitative trait loci influencing LDL size and plasma triglyceride in familial hypertriglyceridemia. J. Lipid. Res. 44, 2161-2168. <https://doi.org/10.1194/jlr.M300272-JLR200>
11. Austin, M. A., Talmud, P. J., Farin, F. M., Nickerson, D. A., Edwards, K. L., Leonetti, D., McNeely, M. J., Viernes, H. M., Humphries, S. E., Fujimoto, W. Y. (2004) Association of apolipoprotein A5 variants with LDL particle size and triglyceride in Japanese Americans. Biochim. Biophys. Acta 1688, 1-9. <https://doi.org/10.1016/j.bbadis.2003.10.003>
12. Baum, L., Tomlinson, B., Thomas, G. N. (2003) APOA51131T>C polymorphism is associated with triglyceride levels in Chinese men. Clin. Genet. 63, 377-379. <https://doi.org/10.1034/j.1399-0004.2003.00063.x>
13. Beaumont, M. A., Rannala, B. (2004) The Bayesian Revolution in Genetics. Nat. Rev. Genet. 5, 251-261. <https://doi.org/10.1038/nrg1318>
14. Bodnar, J. S., Chatterjee, A., Castellani, L. W., Ross, D. A., Ohmen, J., Cavalcoli, J., Wu, C., Dains, K. M., Catanese, J., Chu, M., Sheth, S. S., Charugundla, K., Demant, P., West, D. B., de Jong, P., Lusis, A. J (2002) Positional cloning of the combined hyperlipidemia gene Hyplip1. Nat. Genet. 30, 110-116. <https://doi.org/10.1038/ng811>
15. Borecki, I. B. (2003) Linkage and association studies. In: Nature Encyclopedia of the Human Genome, pp. 718-722, Macmillan Publishers Ltd, Nature Publishing Group, London, UK.
16. Bosse, Y., Chagnon, Y. C., DespresJean-Pierre, J. P., Rice, T., Rao, D. C., Bouchard, C., Perusse, L., Vohl, M. C. (2004a) Genome-wide linkage scan reveals multiple susceptibility loci influencing lipid and lipoprotein levels in the Quebec family study. J. Lipid Res. 45, 419-426. <https://doi.org/10.1194/jlr.M300401-JLR200>
17. Bosse, Y., Perusse, L., Vohl, M. C. (2004b) Genetics of LDL particle heterogeneity: From genetic epidemiology to DNA-based variations. J. Lipid Res. (in press: <https://doi.org/10.1194/jlr.R400002-JLR200>
18. Bottger, A., van Lith, H. A., Křen, V., Křenová, D., Bílá, V., Vorlíček, J., Zídek, V., Musilová, A., Zdobinská, M., Wang, J. M., van Zutphen, B. F., Kurtz, T. W., Pravenec, M. (1996) Quantitative trait loci influencing cholesterol and phospholipid phenotypes map to chromosomes that contain genes regulating blood pressure in the spontaneously hypertensive rat. J. Clin. Invest. 98, 856-862. <https://doi.org/10.1172/JCI118858>
19. Bottini, N., MacMurray, J., Peters, W., Rostamkhani, M., Comings, D. E. (2002) Association of the acid phosphatase (ACP1) gene with triglyceride levels in obese women. Mol. Genet. Metab. 77, 226-229. <https://doi.org/10.1016/S1096-7192(02)00120-8>
20. Breckenridge, W. C., Little, J. A., Alaupovic, P., Wang, C. S., Kuksis, A., Kakis, G., Lindgren, F., Gardiner, G. (1982) Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase. Atherosclerosis 45, 161-179. <https://doi.org/10.1016/0021-9150(82)90136-8>
21. Brisson, D., Ledoux, K., Bosse, Y., St-Pierre, J., Julien, P., Perron, P., Hudson, T. J., Vohl, M. C., Gaudet, D. (2002) Effect of apolipoprotein E, peroxisome proliferator-activated receptor alpha and lipoprotein lipase gene mutations on the ability of fenofibrate to improve lipid profiles and reach clinical guideline targets among hypertriglyceridemic patients. Pharmacogenetics 12, 313-320. <https://doi.org/10.1097/00008571-200206000-00007>
22. Broeckel, U., Hengstenberg, C., Mayer, B., Holmer, S., Martin, L. J., Comuzzie, A. G., Blangero, J., Nurnberg, P., Reis, A., Riegger, G. A., Jacob, H. J., Schunkert, H. (2002) A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat. Genet. 30, 210-214. <https://doi.org/10.1038/ng827>
23. Cassader, M., Ruiu, G., Gambino, R., Guzzon, F., Pagano, A., Veglia, F., Pagni, R., Pagano, G. (1994) Influence of apolipoprotein H polymorphism on levels of triglycerides. Atherosclerosis 110, 45-51. <https://doi.org/10.1016/0021-9150(94)90066-3>
24. Chamberlain, J. C., Thorn, J. A., Oka, K., Galton, D. J., Stocks, J. (1989) DNA polymorphisms at the lipoprotein lipase gene: associations in normal and hypertriglyceridaemic subjects. Atherosclerosis. 79, 85-91. <https://doi.org/10.1016/0021-9150(89)90037-3>
25. Clee, S. M., Zwinderman, A. H., Engert, J. C., Zwarts, K. Y., Molhuizen, H. O., Roomp, K., Jukema, J. W., van Wijland, M., van Dam, M., Hudson, T. J., Brooks-Wilson, A., Genest, J. Jr., Kastelein, J. J., Hayden, M. R. (2001) Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation 103, 1198-1205. <https://doi.org/10.1161/01.CIR.103.9.1198>
26. Cole, S. A., Szathmary, E. J., Ferrell, R. E. (1989) Gene and gene-product variation in the apolipoprotein A-I/C-III/AIV cluster in the Dogrib Indians of the Northwest Territories. Am. J. Hum. Genet. 44, 835-843.
27. Collison, M., Glazier, A. M., Graham, D., Morton, J. J., Dominiczak, M. H., Aitman, T. J., Connell, J. M., Gould, G. W., Dominiczak, A. F. (2000) Cd36 and molecular mechanisms of insulin resistance in the stroke-prone spontaneously hypertensive rat. Diabetes 49, 2222-6. <https://doi.org/10.2337/diabetes.49.12.2222>
28. Comings, D. E., MacMurray, J. P., Gonzalez, N., Ferry, L., Peters, W. R. (1999) Association of the serotonin transporter gene with serum cholesterol levels and heart disease. Mol. Genet. Metab. 67, 248-253. <https://doi.org/10.1006/mgme.1999.2870>
29. Coon, H., Leppert, M. F., Eckfeldt, J. H., Oberman, A., Myers, R. H., Peacock, J. M., Province, M. A., Hopkins, P. N., Heiss, G. (2001) Genome-wide linkage analysis of lipids in the Hypertension Genetic Epidemiology Network (HyperGEN) Blood Pressure Study. Arterioscler. Thromb. Vasc. Biol. 21, 1969-1976. <https://doi.org/10.1161/hq1201.100228>
30. Crosson, S. M., Khan, A., Printen, J., Pessin, J. E., Saltiel, A. R. (2003) PTG gene deletion causes impaired glycogen synthesis and developmental insulin resistance. J. Clin. Invest. 111, 1423-1432. <https://doi.org/10.1172/JCI17975>
31. Couture, P., Otvos, J. D., Cupples, L. A., Wilson, P. W., Schaefer, E. J., Ordovas, J. M. (1999) Association of the A204C polymorphism in the cholesterol 7alpha-hydroxylase gene with variations in plasma low density lipoprotein cholesterol levels in the Framingham Offspring Study J. Lipid Res. 40, 1883-1889. <https://doi.org/10.1016/S0022-2275(20)34905-1>
32. Cowley, A. W. Jr. (2003) Genomics and homeostasis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284, R611-R627. <https://doi.org/10.1152/ajpregu.00567.2002>
33. Cowley, A. W. Jr., Roman, R. J., Jacob, H. J. (2004) Application of chromosomal substitution techniques in gene-function discovery. J. Physiol. 554 (Pt 1), 46-55. <https://doi.org/10.1113/jphysiol.2003.052613>
34. Dahlen, G., Berg, K. (1976) Further evidence for the existence of genetically determined metabolic difference between Lp(a+) and Lp(a-) individuals. Clin. Genet. 9, 357-364. <https://doi.org/10.1111/j.1399-0004.1976.tb01587.x>
35. Dallinga-Thie, G. M., van Linde-Sibenius Trip, M., Rotter, J. I., Cantor, R. M., Bu, X., Lusis, A. J., de Bruin, T. W. (1997) Complex genetic contribution of the Apo AI-CIIIAIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes. J. Clin. Invest. 99, 953-961. <https://doi.org/10.1172/JCI119260>
36. Duggirala, R., Stern, M. P., Mitchell, B. D., Reinhart, L. J., Shipman, P. A., Uresandi, O. C., Chung, W. K., Leibel R. L., Hales, C. N., O'Connell P., Blangero J. (1996) Quantitative variation in obesity related traits and insulin precursors linked to the OB gene region on human chromosome 7. Am. J. Hum. Genet. 59, 694-703.
37. Duggirala, R., Blangero, J., Almasy, L., Dyer, T. D., Williams, K. L., Leach, R. J., O'Connell P., Stern, M. P. (2000) A major susceptibility locus influencing plasma triglyceride concentrations is located on chromosome 15q in Mexican Americans. Am. J. Hum. Genet. 66, 1237-1245. <https://doi.org/10.1086/302849>
38. Duggirala, R., Blangero, J., Almasy, L., Arya, R., Dyer, T. D., Williams, K. L., Leach, R. J., O'Connell, P., Stern, M. P. (2001) A major locus for fasting insulin concentrations and insulin resistance on chromosome 6q with strong pleiotropic effects on obesity-related phenotypes in nondiabetic Mexican Americans. Am. J. Hum. Genet. 68, 1149-1164. <https://doi.org/10.1086/320100>
39. Eichenbaum-Voline, S., Olivier, M., Jones, E. L., Naoumova, R. P., Jones, B., Gau, B., Patel, H. N., Seed, M., Betteridge, D. J., Galton, D. J., Rubin, E. M., Scott, J., Shoulders, C. C., Pennacchio, L. A. (2004) Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 24, 167-174. <https://doi.org/10.1161/01.ATV.0000099881.83261.D4>
40. Elbein, S. C., Hasstedt, S. J. (2002) Quantitative trait linkage analysis of lipid-related traits in familial type 2 diabetes: evidence for linkage of triglyceride levels to chromosome 19q. Diabetes 51, 528-535. <https://doi.org/10.2337/diabetes.51.2.528>
41. Fallin, M. D., Pulver A. E. (2003) Linkage and association studies: replication. In: Nature Encyclopedia of the Human Genome, pp. 722-727. Macmillan Publishers Ltd, Nature Publishing Group.
42. Ferns, G. A., Shelley, C. S., Stocks, J., Rees, A., Paul, H., Baralle, F., Galton, D. (1986) A DNA polymorphism of the apoprotein AII gene in hypertriglyceridemia. Hum. Genet. 74, 302-306. <https://doi.org/10.1007/BF00282553>
43. Fujita, Y., Ezura, Y., Emi, M., Ono, S., Takada, D., Takahashi, K., Uemura, K., Iino, Y., Katayama, Y., Bujo, H., Saito, Y. (2003) Hypertriglyceridemia associated with amino acid variation asn985tyr of the RP1 gene. J. Hum. Genet. 48, 305-308. <https://doi.org/10.1007/s10038-003-0029-z>
44. Gagnon, F., Jarvik, G. P., Motulsky, A. G., Deeb, S. S., Brunzell, J. D., Wijsman, E. M. (2003) Evidence of linkage of HDL level variation to APOC3 in two samples with different ascertainment. Hum. Genet. 113, 522-533. <https://doi.org/10.1007/s00439-003-1006-5>
45. Gertow, K., Bellanda, M., Eriksson, P., Boquist, S., Hamsten, A., Sunnerhagen, M., Fisher, R. M. (2004) Genetic and structural evaluation of fatty acid transport protein-4 in relation to markers of the insulin resistance syndrome. J. Clin. Endocrinol. Metab. 89, 392-399. <https://doi.org/10.1210/jc.2003-030682>
46. Glazier, A. M., Nadeau, J. H., Aitman, T. J. (2002) Finding genes that underlie complex traits. Science 298, 2345-2349. <https://doi.org/10.1126/science.1076641>
47. Gotoda, T., Iizuka, Y., Kato, N., Osuga, J., Bihoreau, M. T., Murakami, T., Yamori, Y., Shimano, H., Ishibashi, S., Yamada, N. (1999) Absence of Cd36 mutation in the original spontaneously hypertensive rats with insulin resistance. Nat. Genet. 22, 226-228. <https://doi.org/10.1038/10285>
48. Hamet, P., Tremblay, J. (2002) Genetic determinants of the stress response in cardiovascular disease. Metabolism 51, 15-24. <https://doi.org/10.1053/meta.2002.33186>
49. Hamet, P., Pausova, Z., Dumas, P., Sun, Y. L., Tremblay, J., Pravenec, M., Kuneš, J., Křenová, D., Křen, V. (1998) Newborn and adult recombinant inbred strains: a tool to search for genetic determinants of target organ damage in hypertension. Kidney Int. 53, 1488-1492. <https://doi.org/10.1046/j.1523-1755.1998.00938.x>
50. Hammond, L. E., Gallagher, P. A., Wang, S., Hiller, S., Kluckman, K. D., Posey-Marcos, E. L., Maeda, N., Coleman, R. A. (2002) Mitochondrial glycerol-3-phosphate acyltransferase-deficient mice have reduced weight and liver triacylglycerol content and altered glycerolipid fatty acid composition. Mol. Cell. Biol. 22, 8204-8214. <https://doi.org/10.1128/MCB.22.23.8204-8214.2002>
51. Hasstedt, S. J., Ren, Q.-F., Teng, K., Elbein, S. C. (2001) Effect of the peroxisome proliferator-activated receptorgamma-2 Pro12Ala variant on obesity, glucose homeostasis, and blood pressure in members of familial type 2 diabetic kindreds. J. Clin. Endocr. Metab. 86, 536-541.
52. Hegele, R. A., Harris, S. B., Hanley, A. J. G., Sadikian, S., Connelly, P. W. Zinman, B. (1996) Genetic variation of intestinal fatty acid-binding protein associated with variation in body mass in aboriginal Canadians. J. Clin. Endocr. Metab. 81, 4334-4337.
53. Henderson, H. E., Landon, S. V., Michie, J., Berger, G. M. B. (1987) Association of a DNA polymorphism in the apolipoprotein C-III gene with diverse hyperlipidaemic phenotypes. Hum. Genet. 75, 62-65. <https://doi.org/10.1007/BF00273841>
54. Herzig, S., Hedrick, S., Morantte, I., Koo, S.-H., Galimi, F., Montminy, M. (2003) CREB controls hepatic lipid metabolism through nuclear hormone receptor PPAR-gamma. Nature 426, 190-193. <https://doi.org/10.1038/nature02110>
55. Hokanson, J. E., Austin, M. A. (1996) Plasma triglyceride is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol: a meta-analysis of population-based prospective studies. J. Cardiovasc. Risk. 3, 213-219. <https://doi.org/10.1097/00043798-199604000-00014>
56. Hong, S. H., Park, W. H., Lee, C. C., Song, J. H., Kim, J. Q. (1997) Association between genetic variations of apo AICIII-AIV cluster gene and hypertriglyceridemic subjects. Clin. Chem. 43, 13-17. <https://doi.org/10.1093/clinchem/43.1.13>
57. Hubáček, J. A., Škodová, Z., Adámková, V., Lánská, V., Poledne, R. (2004) The influence of APOAV polymorphisms (T-1131>C and S19>W) on plasma triglyceride levels and risk of myocardial infarction. Clin. Genet. 65, 126-130. <https://doi.org/10.1111/j.0009-9163.2004.00199.x>
58. Humphries, S. E., Lane, A., Green, F. R., Cooper, J., Miller, G. J. (1994) Factor VII coagulant activity and antigen levels in healthy men are determined by interaction between factor VII genotype and plasma triglyceride concentration. Arterioscler. Thromb. 14, 193-198. <https://doi.org/10.1161/01.ATV.14.2.193>
59. Imperatore, G., Knowler, W. C., Pettitt, D. J., Kobes, S., Fuller, J. H., Bennett, P. H., Hanson, R. L. (2000) A locus influencing total serum cholesterol on chromosome 19p: results from an autosomal genomic scan of serum lipid concentrations in Pima Indians. Arterioscler. Thromb. Vasc. Biol. 20, 2651-2656. <https://doi.org/10.1161/01.ATV.20.12.2651>
60. Iwai, N., Katsuya, T., Mannami, T., Higaki, J., Ogihara, T., Kokame, K., Ogata, J., Baba, S. (2002) Association between SAH, an acyl-CoA synthetase gene, and hypertriglyceridemia, obesity, and hypertension. Circulation 105, 41-47. <https://doi.org/10.1161/hc0102.101780>
61. Jacob, H. J., Kwitek, A. E. (2002) Rat genetics: attaching physiology and pharmacology to the genome. Nat. Rev. Genet. 3, 33-42. <https://doi.org/10.1038/nrg702>
62. Jeppesen, J., Hein, H. O., Suadicani, P., Gyntelberg, F. (1998) Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. Circulation 97, 1029-1036. <https://doi.org/10.1161/01.CIR.97.11.1029>
63. Kamboh, M. I., Aston, C. E., Hamman, R. F. (2000) DNA sequence variation in human apolipoprotein C4 gene and its effect on plasma lipid profile. Atherosclerosis 152, 193-201. <https://doi.org/10.1016/S0021-9150(99)00459-1>
64. Karvonen, M. K., Koulu, M., Pesonen, U., Uusitupa, M. I. J., Tammi, A., Viikari, J., Simell, O., Ronnemaa, T. (2000) Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with birth weight and serum triglyceride concentration in preschool-aged children. J. Clin. Endocr. Metab. 85, 1455-1460.
65. Katsuya, T., Horiuchi, M., Chen, Y. D., Koike, G., Pratt, R. E., Dzau, V. J., Reaven, G. M. (1995) Relations between deletion polymorphism of the angiotensin-converting enzyme gene and insulin resistance, glucose intolerance, hyperinsulinemia, and dyslipidemia. Arterioscler. Thromb. Vasc. Biol. 15, 779-782. <https://doi.org/10.1161/01.ATV.15.6.779>
66. Kim-Motoyama, H., Yasuda, K., Yamaguchi, T., Yamada, N., Katakura, T., Shuldiner, A. R., Akanuma, Y., Ohashi, Y., Yazaki, Y., Kadowaki, T. (1997) A mutation of the beta-3adrenergic receptor is associated with visceral obesity but decreased serum triglyceride. Diabetologia 40, 469-472. <https://doi.org/10.1007/s001250050702>
67. Kissebah, A. H., Sonnenberg, G. E., Myklebust, J., Goldstein, M., Broman, K., James, R. G., Marks, J. A., Krakower, G. R., Jacob, H. J., Weber, J., Martin, L., Blangero, J., Comuzzie, A. G. (2000) Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc. Natl. Acad. Sci. USA 97, 14478-14483. <https://doi.org/10.1073/pnas.97.26.14478>
68. Klimeš, I., Weston, K., Kovacs, P., Gašperíková, D., Ježová, D., Květnanský, R., Thompson, J. R., Šeboková, E., Samani, N. J. (2003) Mapping of genetic loci predisposing to hypertriglyceridaemia in the hereditary hypertriglyceridaemic rat: analysis of genetic association with related traits of the insulin resistance syndrome. Diabetologia 46, 352-358. <https://doi.org/10.1007/s00125-003-1035-6>
69. Klos, K. L., Kardia, S. L., Ferrell, R. E., Turner, S. T., Boerwinkle, E., Sing, C. F. (2001) Genome-wide linkage analysis reveals evidence of multiple regions that influence variation in plasma lipid and apolipoprotein levels associated with risk of coronary heart disease. Arterioscler. Thromb. Vasc. Biol. 21, 971-978. <https://doi.org/10.1161/01.ATV.21.6.971>
70. Kloting, I., Kovacs, P., van den Brandt, J. (2001a) Quantitative trait loci for body weight, blood pressure, blood glucose, and serum lipids: linkage analysis with wild rats (Rattus norvegicus). Biochem. Biophys. Res. Commun. 284, 1126-1133. <https://doi.org/10.1006/bbrc.2001.5091>
71. Kloting, I., Kovacs, P., van den Brandt, J. (2001b) Sex-specific and sex-independent quantitative trait loci for facets of the metabolic syndrome in WOKW rats. Biochem. Biophys. Res. Commun. 284, 150-156. <https://doi.org/10.1006/bbrc.2001.4932>
72. Koishi, R., Ando, Y., Ono, M., Shimamura, M., Yasumo, H., Fujiwara, T., Horikoshi, H., Furukawa, H. (2002) Angptl3 regulates lipid metabolism in mice. Nat. Genet. 30, 151-157. <https://doi.org/10.1038/ng814>
73. Kokaze, A., Ishikawa, M., Matsunaga, N., Yoshida, M., Sekine, Y., Teruya, K., Takeda, N., Sumiya, Y., Uchida, Y., Takashima, Y. (2001) Association of the mitochondrial DNA 5178 A/C polymorphism with serum lipid levels in the Japanese population. Hum. Genet. 109, 521-525. <https://doi.org/10.1007/s004390100602>
74. Kovacs, P., Kloting, I. (1998) Quantitative trait loci on chromosomes 1 and 4 affect lipid phenotypes in the rat. Arch. Biochem. Biophys. 354, 139-143. <https://doi.org/10.1006/abbi.1998.0686>
75. Kovacs, P., van den Brandt, J., Kloting, I. (1998) Effects of quantitative trait loci for lipid phenotypes in the rat are influenced by age. Clin. Exp. Pharmacol. Physiol. 25, 1004-1007. <https://doi.org/10.1111/j.1440-1681.1998.tb02174.x>
76. Kovacs, P., van den Brandt, J., Kloting, I. (2000) Genetic dissection of the syndrome X in the rat. Biochem. Biophys. Res. Commun. 269, 660-665. <https://doi.org/10.1006/bbrc.2000.2352>
77. Křen, V., Křenová, D., Pravenec, M., Zdobinská, M. (1995) Chromosome 8 congenic strains: tools for genetic analysis of limb malformation, plasma triglycerides, and blood pressure in the rat. Folia Biol. (Praha) 41, 284-293.
78. Křen, V., Křenová, D., Bílá, V., Zdobinská, M., Zídek, V., Pravenec, M. (1996) Recombinant inbred and congenic strains for mapping of genes that are responsible for spontaneous hypertension and other risk factors of cardiovascular disease. Folia Biol. (Praha) 42, 155-158.
79. Křen, V., Pravenec, M., Lu, S., Křenová, D., Wang, J.-M., Wang, N., Merriouns, T., Wong, A., St. Lezin, E., Lau, D., Szpirer, C., Szpirer, J., Kurtz, T.W. (1997) Genetic isolation of a region of chromosome 8 that exerts major effects on blood pressure and cardiac mass in the spontaneously hypertensive rat. J. Clin. Invest. 99, 577-581. <https://doi.org/10.1172/JCI119198>
80. Křenová, D., Šoltysová, L., Pravenec, M., Moisan, M. P., Kurtz, T.W., Křen, V. (2000) Putative candidate genes for blood pressure control in the SHR.BN-RNO8 congenic substrains. J. Exp. Anim. Sci. 41, 51-53. <https://doi.org/10.1016/S0939-8600(00)80029-2>
81. Lavebratt, C., Ryden, M., Schalling, M., Sengul, S., Ahlberg, S., Hoffstedt, J. (2002) The hormone-sensitive lipase i6 gene polymorphism and body fat accumulation. Eur. J. Clin. Invest. 32, 938-942. <https://doi.org/10.1046/j.1365-2362.2002.01075.x>
82. Law, A., Wallis, S. C., Powell, L. M., Pease, R. J., Brunt, H., Priestley, L. M., Knott, T. J., Scott, J., Altman, D. G., Miller, G. J., Rajput, J., Miller, N. E. (1986) Common DNA polymorphism within coding sequence of apolipoprotein B gene associated with altered lipid levels. Lancet 1, 1301-1303. <https://doi.org/10.1016/S0140-6736(86)91222-5>
83. Lin, J.-P. (2003) Genome-wide scan on plasma triglyceride and high density lipoprotein cholesterol levels, accounting for the effects of correlated quantitative phenotypes. BMC Genetics 4 (Suppl. 1), S47. <https://doi.org/10.1186/1471-2156-4-S1-S47>
84. Liška, F., Levan, G., Helou, K., Sladká, M., Pravenec, M., Zídek, V., Landa, V., Křen, V. (2002) Chromosome assignment of Cd36 transgenes in two rat SHR lines by FISH and linkage mapping of transgenic insert in the SHR-TG19 line. Folia Biol. (Praha) 48, 139-144.
85. Mar, R., Pajukanta, P., Allayee, H., Groenendijk, M., Dallinga-Thie, G., Krauss, R. M., Sinsheimer, J. S., Cantor, R. M., De Bruin, T. W., Lusis, A. J. (2004) Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia. Circ. Res. (in press: <https://doi.org/10.1161/01.RES.0000124922.61830.F0>
86. Martinez-Chantar, M. L., Corrales, F. J., Martinez-Cruz, L. A., Garcia-Trevijano, E. R., Huang, Z. Z., Chen, L., Kanel, G., Avila, M. A., Mato, J. M., Lu, S. C. (2002) Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A. FASEB J. 16, 1292-1294. <https://doi.org/10.1096/fj.02-0078fje>
87. Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., Flier, J. S. (2001) A transgenic model of visceral obesity and the metabolic syndrome. Science 294, 2166-2170. <https://doi.org/10.1126/science.1066285>
88. Meirhaeghe, A., Martin, G., Nemoto, M., Deeb, S., Cottel, D., Auwerx, J., Amouyel, P., Helbecque, N. (2000) Intronic polymorphism in the fatty acid transport protein 1 gene is associated with increased plasma triglyceride levels in a French population. Arterioscler. Thromb. Vasc. Biol. 20, 1330-1334. <https://doi.org/10.1161/01.ATV.20.5.1330>
89. Meirhaeghe, A., Helbecque, N., Cottel, D., Arveiler, D., Ruidavets, J.-B., Haas, B., Ferrieres, J., Tauber, J.-P., Bingham, A., Amouyel, P. (2001) Impact of sulfonylurea receptor 1 genetic variability on non-insulin-dependent diabetes mellitus prevalence and treatment: a population study. Am. J. Med. Genet. 101, 4-8. <https://doi.org/10.1002/ajmg.1297>
90. Menzel, H.-J., Boerwinkle, E., Schrangl-Will, S., Utermann, G. (1988) Human apolipoprotein A-IV polymorphism: frequency and effect on lipid and lipoprotein levels. Hum. Genet. 79, 368-372. <https://doi.org/10.1007/BF00282179>
91. Mlejnek, P., Křen, V., Liška, F., Zídek, V., Landa, V., Kurtz, T. W., Pravenec, M. (2003) The CD36 protein functions as an immunogenic domain of the RT8 alloantigen. Eur. J. Immunogenet. 30, 325-327. <https://doi.org/10.1046/j.1365-2370.2003.00410.x>
92. Murray, I., Sniderman, A. D., Cianflone, K. (1999) Mice lacking acylation stimulating protein (ASP) have delayed postprandial triglyceride clearance. J. Lipid Res. 40, 1671-1676. <https://doi.org/10.1016/S0022-2275(20)33413-1>
93. Naoumova, R. P., Bonney, S. A., Eichenbaum-Voline, S., Patel, H. N., Jones, B., Jones, E. L., Amey, J., Colilla, S., Neuwirth, C. K., Allotey, R., Seed, M., Betteridge, D. J., Galton, D. J., Cox, N. J., Bell, G. I., Scott, J., Shoulders, C. C. (2003) Confirmed locus on chromosome 11p and candidate loci on 6q and 8p for the triglyceride and cholesterol traits of combined hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 23, 2070-2077. <https://doi.org/10.1161/01.ATV.0000095975.35247.9F>
94. Newman, D. L., Abney, M., Dytch, H., Parry, R., McPeek, M. S., Ober, C. (2003) Major loci influencing serum triglyceride levels on 2q14 and 9p21 localized by homozygosityby-descent mapping in a large Hutterite pedigree. Hum. Mol. Genet. 12, 137-144. <https://doi.org/10.1093/hmg/ddg012>
95. Nielsen, E. M., Hansen, L., Echwald, S. M., Drivsholm, T., Borch-Johnsen, K., Ekstrom, C. T., Hansen, T., Pedersen, O. (2003) Evidence for an association between the Leu162Val polymorphism of the PPARalpha gene and decreased fasting serum triglyceride levels in glucose tolerant subjects. Pharmacogenetics 13, 417-423. <https://doi.org/10.1097/00008571-200307000-00007>
96. Nishina, P. M., Johnson, J. P., Naggert, J. K., Krauss, R. M. (1992) Linkage of atherogenic lipoprotein phenotype to the low density lipoprotein receptor locus on the short arm of chromosome 19. Proc. Nat. Acad. Sci. USA 89, 708-712. <https://doi.org/10.1073/pnas.89.2.708>
97. Nishina, P. M., Lowe, S., Wang, J., Paigen, B. (1994) Characterization of plasma lipids in genetically obese mice: the mutants obese, diabetes, fat, tubby, and lethal yellow. Metabolism 43, 549-553. <https://doi.org/10.1016/0026-0495(94)90194-5>
98. Nobrega, M. A., Penacchio, L. A. (2003) Comparative genomic analysis as a tool for biological discovery. J. Physiol. 554, 31-39. <https://doi.org/10.1113/jphysiol.2003.050948>
99. Norum, K. R., Gjone, E. (1967) Familial plasma lecithin:cholesterol acyltransferase deficiency: biochemical study of a new inborn error of metabolism. Scand. J. Clin. Lab. Invest. 20, 231-243. <https://doi.org/10.3109/00365516709076948>
100. Ogino, T., Wei, S., Wei, K., Moralejo, D. H., Kose, H., Mizuno, A., Shima, K., Sasaki, Y., Yamada, T., Matsumoto, K. (2000) Genetic evidence for obesity loci involved in the regulation of body fat distribution in obese type 2 diabetes rat, OLETF. Genomics 70, 19-25. <https://doi.org/10.1006/geno.2000.6349>
101. Okuno, S., Watanabe, T. K., Ono, T., Yamasaki, Y., Goto, Y., Miyao, H., Asai, T., Kanemoto, N., Oga, K., Mizoguchi-Miyakita, A., Takagi, T., Takahashi, E., Nakamura, Y., Tanigami, A. (1999) Genetic determinants of plasma triglyceride levels in (OLETF x BN) x OLETF backcross rats. Genomics 62, 350-355. <https://doi.org/10.1006/geno.1999.6018>
102. Orho-Melander, M., Almgren, P., Kanninen, T., Forsblom, C., Groop, L. C. (1999) A paired-sibling analysis of the XbaI polymorphism in the muscle glycogen synthase gene. Diabetologia 42, 1138-1145. <https://doi.org/10.1007/s001250051282>
103. Pajukanta, P., Nuotio, I., Terwilliger, J. D., Porkka, K. V., Ylitalo, K., Pihlajamaki, J., Suomalainen, A. J., Syvanen, A. C., Lehtimaki, T., Viikari, J. S., Laakso, M., Taskinen, M. R., Ehnholm, C, Peltonen, L. (1998) Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23. Nat. Genet. 18, 369-373. <https://doi.org/10.1038/ng0498-369>
104. Pajukanta, P., Lilja, H.E., Sinsheimer, J. S., Cantor, R. M., Lusis, A. J., Gentile, M., Duan, X. J., Soro-Paavonen, A., Naukkarinen, J., Saarela, J., Laakso, M., Ehnholm, C., Taskinen, M. R., Peltonen, L. (2004) Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1). Nat. Genet. 36, 371-376. <https://doi.org/10.1038/ng1320>
105. Pausova, Z., Gossard, F., Gaudet, D., Tremblay, J., Kotchen, T. A., Cowley, A. W., Hamet, P. (2001) Heritability estimates of obesity measures in siblings with and without hypertension. Hypertension 38, 41-47. <https://doi.org/10.1161/01.HYP.38.1.41>
106. Pausova, Z., Jomphe, M., Houde, L., Vezina, H., Orlov, S. N., Gossard, F., Gaudet, D., Tremblay, J., Kotchen, T. A., Cowley, A. W., Bouchard, G., Hamet, P. (2002) A genealogical study of essential hypertension with and without obesity in French Canadians. Obes. Res. 10, 463-470. <https://doi.org/10.1038/oby.2002.64>
107. Pausova, Z., Šedová, L., Bérubé, J., Hamet, P., Tremblay, J., Dumont, M., Gaudet, D., Pravenec, M., Křen, V., Kuneš, J. (2003) A segment of rat chromosome 20 regulates dietinduced augmentations in adiposity, glucose intolerance, and blood pressure. Hypertension 41, 1047-1055. <https://doi.org/10.1161/01.HYP.0000064347.49341.0B>
108. Pennacchio, L. A., Olivier, M., Hubacek, J. A., Cohen, J. C., Cox, D. R., Fruchart, J.-C., Krauss, R. M, Rubin, E. M. (2001) An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294, 169-173. <https://doi.org/10.1126/science.1064852>
109. Pravenec, M., Klír, P., Křen, V., Zicha, J., Kuneš, J. (1989) An analysis of spontaneous hypertension in spontaneously hypertensive rats by means of new recombinant inbred strains. J. Hypertens. 3, 217-221.
110. Pravenec, M., Gauguier, D., Schott, J. J., Buard, J., Kren, V., Bila, V., Szpirer, C., Szpirer, J., Wang, J. M., Huang, H., St. Lezin, E., Spence, M. A., Flodman, P., Printz, M., Lathrop, G. M., Vergnaud, G., Kurtz, T. (1995) Mapping of quantitative trait loci for blood pressure and cardiac mass in the rat by genome scanning of recombinant inbred strains. J. Clin. Invest. 96, 1973-1978. <https://doi.org/10.1172/JCI118244>
111. Pravenec, M., Zídek, V., Šimáková, M., Křen, V., Křenová, D., Horký, K., Jáchymová, M., Míková, B., Kazdová, L., Aitman, T. J., Churchill, P. C., Webb, R. C., Hingarh, N. H., Yang, Y., Wang, J. M., St Lezin, E. M., Kurtz, T. W. (1999) Genetics of Cd36 and the clustering of multiple cardiovascular risk factors in spontaneous hypertension. J. Clin. Invest. 103, 1651-1657. <https://doi.org/10.1172/JCI6691>
112. Pravenec, M., Zídek, V., Landa, V., Kostka, V., Musilová, A., Kazdová, L., Fučíková, A., Křenová, D., Bílá, V., Křen, V. (2000) Genetic analysis of cardiovascular risk factor clustering in spontaneous hypertension. Folia Biol. (Praha) 46, 233-240.
113. Pravenec, M.., Landa, V., Zídek, V., Musilová, A., Křen, V., Kazdová, L., Aitman, T. J., Glazier, A. M., Ibrahimi, A., Abumrad, N. A., Qi, N., Wang, J., St. Lezin, E., Kurtz, T. W. (2001a) Transgenic rescue of defective Cd36 ameliorates insulin resistance in spontaneously hypertensive rats. Nat. Genet. 27, 156-158. <https://doi.org/10.1038/84777>
114. Pravenec, M., Jansa, P., Kostka, V., Zídek, V., Křen, V., Forejt, J., Kurtz, T. W. (2001b) Identification of a mutation in ADD1/SREBP-1 in the spontaneously hypertensive rat. Mamm. Genome 12, 295-298. <https://doi.org/10.1007/s003350010273>
115. Pravenec, M., Zídek, V., Musilová, A., Šimáková, M., Kostka, V., Mlejnek, P., Křen, V., Křenová, D., Bílá, V., Míková, B., Jáchymová, M., Horký, K., Kazdová, L., St. Lezin, E., Kurtz, T. W. (2002) Genetic analysis of metabolic defects in the spontaneously hypertensive rat. Mamm. Genome 13, 253-258. <https://doi.org/10.1007/s00335-001-2078-y>
116. Pravenec, M., Kurtz, T. W. (2002) Genetics of Cd36 and the hypertension metabolic syndrome. Semin. Nephrol. 22, 148-153. <https://doi.org/10.1053/snep.2002.2002.30218>
117. Pravenec, M., Landa, V., Zídek, V., Musilová, A., Kazdová, L., Qi, N., Wang, J., St. Lezin, E., Kurtz, T. W. (2003) Transgenic expression of CD36 in the spontaneously hypertensive rat is associated with amelioration of metabolic disturbances but has no effect on hypertension. Physiol. Res. 52, 681-688. <https://doi.org/10.33549/physiolres.930380>
118. Pravenec, M., Zídek, V., Landa, V., Šimáková, M., Mlejnek, P., Kazdová, L., Bílá, V., Křenová, D., Křen, V. (2004) Genetic analysis of the ìmetabolic syndromeî in the spontaneously hypertensive rat. Physiol. Res. 53 (Suppl. 1) in press.
119. Qi, N., Kazdová, L., Zídek, V., Landa, V., Křen, V., Pershadsingh, H. A., St. Lezin, E., Abumrad, N. A., Pravenec, M., Kurtz, T. W. (2002) Pharmacogenetic evidence that Cd36 is a key determinant of the metabolic effects of pioglitazone. J. Biol. Chem. 277, 48501-48507. <https://doi.org/10.1074/jbc.M206655200>
120. Rainwater, D. L., Almasy, L., Blangero, J., Cole, S. A., VandeBerg, J. L., MacCluer, J. W., Hixson, J. E. (1999) A genome search identifies major quantitative trait loci on human chromosomes 3 and 4 that influence cholesterol concentrations in small LDL particles. Arterioscler. Thromb. Vasc. Biol. 19, 777-783. <https://doi.org/10.1161/01.ATV.19.3.777>
121. Rapp, J. P. (2000) Genetic analysis of inherited hypertension in the rat. Physiol. Rev. 80, 135-172. <https://doi.org/10.1152/physrev.2000.80.1.135>
122. Rat Genome Sequencing Project Consortium (2004) Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature 428, 493-521. <https://doi.org/10.1038/nature02426>
123. Reed, D. R., Nanthakumar, E., North, M., Bell, C., Price, R. A. (2001) A genome-wide scan suggests a locus on chromosome 1q21-q23 contributes to normal variation in plasma cholesterol concentration. J. Mol. Med. 79, 262-269. <https://doi.org/10.1007/s001090100212>
124. Repa, J. J., Lund, E. G., Horton, J. D., Leitersdorf, E., Russell, D. W., Dietschy, J. M., Turley, S. D. (2000) Disruption of the sterol 27-hydroxylase gene in mice results in hepatomegaly and hypertriglyceridemia. Reversal by cholic acid feeding. J. Biol. Chem. 275, 39685-39692. <https://doi.org/10.1074/jbc.M007653200>
125. Rodondi, N., Darioli, R., Ramelet, A. A., Hohl, D., Lenain, V., Perdrix, J., Wietlisbach, V., Riesen, W. F., Walther, T., Medinger, L., Nicod, P., Desvergne, B., Mooser, V. (2002) High risk for hyperlipidemia and the metabolic syndrome after an episode of hypertriglyceridemia during 13-cis retinoic acid therapy for acne: a pharmacogenetic study. Ann. Intern. Med. 136, 582-589. <https://doi.org/10.7326/0003-4819-136-8-200204160-00007>
126. Saha, N., Roy, A. C., Teo, S. H., Tay, J. S., Ratnam, S. S. (1991) Influence of serum paraoxonase polymorphism on serum lipids and apolipoproteins. Clin. Genet. 40, 277-282. <https://doi.org/10.1111/j.1399-0004.1991.tb03096.x>
127. Sato, K., Emi, M., Ezura, Y., Fujita, Y., Takada, D., Ishigami, T., Umemura, S., Xin, Y., Wu, L. L., Larrinaga-Shum, S., Stephenson, S. H., Hunt, S. C., Hopkins, P. N. (2004) Soluble epoxide hydrolase variant (Glu287Arg) modifies plasma total cholesterol and triglyceride phenotype in familial hypercholesterolemia: intrafamilial association study in an eight-generation hyperlipidemic kindred. J. Hum. Genet. 49, 29-34. <https://doi.org/10.1007/s10038-003-0103-6>
128. Schmidt, H. H., Genschel, J., Baier, P., Schmidt, M., Ockenga, J., Tietge, U. J. F., Propsting, M., Buttner, C., Manns, M. P., Lochs, H., Brabant, G. (2001) Dyslipemia in familial partial lipodystrophy caused by an R482W mutation in the LMNA gene. J. Clin. Endocr. Metab. 86, 2289-2295. <https://doi.org/10.1210/jcem.86.5.7500>
129. Shearman, A. M., Ordovas, J. M., Cupples, L. A., Schaefer, E. J., Harmon, M. D., Shao, Y., Keen, J. D., DeStefano, A. L., Joost, O., Wilson, P. W., Housman, D. E., Myers, R. H. (2000) Evidence for a gene influencing the TG/HDL-C ratio on chromosome 7q32.3-qter: a genome-wide scan in the Framingham study. Hum. Mol. Genet. 9, 1315-1320. <https://doi.org/10.1093/hmg/9.9.1315>
130. Shih, D. Q., Dansky, H. M., Fleisher, M., Assmann, G., Fajans, S. S., Stoffel, M. (2000) Genotype/phenotype relationships in HNF-4alpha/MODY1: haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein(a), and triglyceride levels. Diabetes 49, 832-837. <https://doi.org/10.2337/diabetes.49.5.832>
131. Shike, T., Hirose, S., Kobayashi, M., Funabiki, K., Shirai, T., Tomino, Y. (2001) Susceptibility and negative epistatic loci contributing to type 2 diabetes and related phenotypes in a KK/Ta mouse model. Diabetes 50, 1943-1948. <https://doi.org/10.2337/diabetes.50.8.1943>
132. Shimomura, I., Hammer, R. E., Richardson, J. A., Ikemoto, S., Bashmakov, Y., Goldstein, J. L., Brown, M. S. (1998) Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev. 12, 3182-3194. <https://doi.org/10.1101/gad.12.20.3182>
133. Shoulders, C. C., Grantham, T. T., North, J. D., Gaspardone, A., Tomai, F., de Fazio, A., Versaci, F., Gioffre, P. A., Cox, N. J. (1996) Hypertriglyceridemia and the apolipoprotein CIII gene locus: lack of association with the variant insulin response element in Italian school children. Hum. Genet. 98, 557-566. <https://doi.org/10.1007/s004390050259>
134. Smit, G. P. (1993) The long-term outcome of patients with glycogen storage disease type Ia. Eur. J. Pediatr. 152 (Suppl. 1), S52-S55. <https://doi.org/10.1007/BF02072089>
135. Smith, S. J., Cases, S., Jensen, D. R., Chen, H. C., Sande, E., Tow, B., Sanan, D. A., Raber, J., Eckel, R. H., Farese R. V. Jr. (2000) Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat. Nat. Genet. 25, 87-90. <https://doi.org/10.1038/75651>
136. Snyder, E. E., Walts, B., Pérusse, L., Chagnon, Y.C., Weisnagel, S. J., Rankinen, T., Bouchard, C. (2004) The human obesity gene map: the 2003 update. Obes. Res. 12, 369-439. <https://doi.org/10.1038/oby.2004.47>
137. Sonnenberg, G. E., Krakower, G. R., Martin, L. J., Olivier, M., Kwitek, A. E., Comuzzie, A. G., Blangero, J., Kissebah, A. H. (2004) Genetic determinants of obesityrelated lipid traits. J. Lipid Res. 45, 610-615. <https://doi.org/10.1194/jlr.M300474-JLR200>
138. Stoll, M., Cowley, A. W. Jr., Tonellato, P. J., Greene, A. S., Kaldunski, M. L., Roman, R. J., Dumas, P., Schork, N. J., Wang, Z., Jacob, H. J. (2001) A genomic-systems biology map for cardiovascular function. Science 294, 1723-1726. <https://doi.org/10.1126/science.1062117>
139. Stone, S. J., Myers, H. M., Watkins, S. M., Brown, B. E., Feingold, K. R., Elias, P. M., Farese, R. V. Jr. (2004) Lipopenia and skin barrier abnormalities in DGAT2-deficient mice. J. Biol. Chem. 279, 11767-11776. <https://doi.org/10.1074/jbc.M311000200>
140. Suto, J., Matsuura, S., Yamanaka, H., Sekikawa, K. (1999) Quantitative trait loci that regulate plasma lipid concentration in hereditary obese KK and KK-Ay mice. Biochem. Biophys. Acta 1453, 385-395.
141. Suto, J., Sekikawa, K. (2003) Quantitative trait locus analysis of plasma cholesterol and triglyceride levels in KK x RR F2 mice. Biochem. Genet. 41, 325-341. <https://doi.org/10.1023/B:BIGI.0000006033.99978.8b>
142. Suzuki, T., Yokota, H., Yamazaki, T., Kitamura, K., Yamaoki, K., Nagai, R., Yazaki, Y. (1996) Angiotensin converting enzyme polymorphism is associated with severity of coronary heart disease and serum lipids (total cholesterol and triglycerides levels) in Japanese patients. Coron. Artery Dis. 7, 371-375. <https://doi.org/10.1097/00019501-199605000-00007>
143. Šeda, O., Šedová, L. (2003) New apolipoprotein A-V: comparative genomics meets metabolism. Physiol. Res. 52, 141-146. <https://doi.org/10.33549/physiolres.930417>
144. Šeda, O., Šedová, L., Kazdová, L., Křenová, D., Křen, V. (2002a) Metabolic characterization of insulin resistance syndrome feature loci in three Brown Norway-derived congenic strains. Folia Biol. (Praha) 48, 81-88.
145. Šeda, O., Kazdová, L., Křenová, D., Křen, V. (2002b) Rosiglitazone improves insulin resistance, lipid profile and promotes adiposity in genetic model of metabolic syndrome X. Folia Biol. (Praha) 48, 237-241.
146. Šeda, O., Kazdová, L., Křenová, D., Křen, V. (2003a) Rosiglitazone fails to improve hypertriglyceridemia and glucose tolerance in CD36-deficient BN.SHR4 congenic rat strain. Physiol. Genomics 12, 73-78. <https://doi.org/10.1152/physiolgenomics.00113.2002>
147. Šeda, O., Liška, F., Křenová, D., Kazdová, L., Šedová, L., Zima, T., Peng, J., Tremblay, J., Křen, V., Hamet, P. (2003b) Differential linkage of triglyceride and glucose levels on rat chromosome 4 in two segregating rat populations. Folia Biol. (Praha) 49, 223-226.
148. Šedová, L., Kazdová, L., Šeda, O., Křenová, D., Křen, V. (2000a) Rat inbred PD/Cub strain as a model of dyslipidemia and insulin resistance. Folia Biol. (Praha) 46, 99-106.
149. Šedová, L., Křenová, D., Kemlink, D., Pravenec, M., Křen, V. (2000b) Mapping and phenotypic manifestation of the Lx mutation in the SHR-Lx congenic substrains. Rat Genome 6, 72.
150. Šedová, L., Šeda, O., Křenová, D., Křen, V., Kazdová, L. (2004) Isotretinoin and fenofibrate induce adiposity with distinct effect on metabolic profile in a rat model of the insulin resistance syndrome. Int. J. Obes. Relat. Metab. Disord. 28, 719-725. <https://doi.org/10.1038/sj.ijo.0802613>
151. Tai, E. S., Adiconis, X., Ordovas, J. M., Carmena-Ramon, R., Real, J., Corella, D., Ascaso, J., Carmena, R. (2003) Polymorphisms at the SRBI locus are associated with lipoprotein levels in subjects with heterozygous familial hypercholesterolemia. Clin. Genet. 63, 53-58. <https://doi.org/10.1034/j.1399-0004.2003.630108.x>
152. Talmud, P. J., Hawe, E., Martin, S., Olivier, M., Miller, G. J., Rubin, E.M., Pennacchio, L. A., Humphries, S. E. (2002) Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum. Mol. Genet. 11, 3039-3046. <https://doi.org/10.1093/hmg/11.24.3039>
153. Twigger, S. N., Nie, J., Ruotti, V., Yu, J., Chen, D., Li, D., Mathis, J., Narayanasamy, V., Gopinath, G. R., Pasko, D., Shimoyama, M., De La Cruz, N., Bromberg, S., Kwitek, A. E., Jacob, H. J., Tonellato, P. J. (2004) Integrative genomics: in silico coupling of rat physiology and complex traits with mouse and human data. Genome Res. 14, 651-660. <https://doi.org/10.1101/gr.1974504>
154. Ueno, T., Tremblay, J., Kuneš J., Zicha J., Dobešová, Z., Pausova, Z., Deng A. Y., Sun Y.-L., Jacob, H. J., Hamet, P. (2003) Resolving the composite trait of hypertension into its pharmacogenetic determinants by acute pharmacological modulation of blood pressure regulatory systems. J. Mol. Med. 81, 51-60. <https://doi.org/10.1007/s00109-002-0394-7>
155. Ueno, T., Tremblay, J., Kuneš J., Zicha J., Dobešová, Z., Pausova, Z., Deng A. Y., Sun Y.-L., Jacob, H. J., Hamet, P. (2004) Rat model of familial combined hyperlipidemia as a result of comparative mapping. Physiol. Genomics 17, 38-47. <https://doi.org/10.1152/physiolgenomics.00043.2003>
156. Utermann, G., Vogelberg, K. H., Steinmetz, A., Schoenborn, W., Pruin, N., Saeschke, M., Hess, M., Canzler, H. (1979) Polymorphism of apolipoprotein E. II. Genetics of hyperlipoproteinemia type III. Clin. Genet. 15, 37-62. <https://doi.org/10.1111/j.1399-0004.1979.tb02027.x>
157. Utermann, G., Steinmetz, A., Paetzold, R., Wilk, J., Feussner, G., Kaffarnik, H., Mueller-Eckhardt, C., Seidel, D., Vogelberg, K.-H., Zimmer, F. (1982) Apolipoprotein AI Marburg: studies of two kindreds with a mutant of human apolipoprotein AI. Hum. Genet. 61, 329-337. <https://doi.org/10.1007/BF00276597>
158. van der Vliet, H. N., Sammels, M. G., Leegwater, A. C., Levels, J. H., Reitsma, P. H., Boers, W., Chamuleau, R. A. (2001) Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration. J. Biol. Chem. 276, 44512-44520. <https://doi.org/10.1074/jbc.M106888200>
159. Vendrell, J., Gutierrez, C., Pastor, R., Richart, C. (1995) A tumor necrosis factor-beta polymorphism associated with hypertriglyceridemia in non-insulin-dependent diabetes mellitus. Metabolism 44, 691-694. <https://doi.org/10.1016/0026-0495(95)90177-9>
160. Vrána, A., Kazdová L., Dobešová, Z., Kuneš, J., Křen, V., Bílá, V., Štolba, P., Klimeš, I. (2003) Triglyceridemia, glucoregulation, and blood pressure in various rat strains. Effects of dietary carbohydrates. Ann. N. Y. Acad. Sci. 683, 57-68. <https://doi.org/10.1111/j.1749-6632.1993.tb35692.x>
161. Wang, J., Near, S., Young, K., Connelly, P. W., Hegele, R. A. (2001) ABCC6 gene polymorphism associated with variation in plasma lipoproteins. J. Hum. Genet. 46, 699-705. <https://doi.org/10.1007/s100380170003>
162. Wang, H., Chu, W., Hemphill, C., Hasstedt, S. J., Elbein, S. C. (2002) Mutation screening and association of human retinoid X receptor gamma variation with lipid levels in familial type 2 diabetes. Mol. Genet. Metab. 76, 14-22. <https://doi.org/10.1016/S1096-7192(02)00016-1>
163. Wang, H., Chu, W. S., Lu, T., Hasstedt, S. J., Kern, P. A., Elbein, S. C. (2004) Uncoupling protein-2 polymorphisms in type 2 diabetes, obesity, and insulin secretion. Am. J. Physiol. Endocrinol. Metab. 286, E1-7. <https://doi.org/10.1152/ajpendo.00231.2003>
164. Waterworth, D. M., Talmud, P. J., Humphries, S. E., Wicks, P. D., Sagnella, G. A., Strazzullo, P., Alberti, K. G., Cook, D. G., Cappuccio, F. P. (2001) Variable effects of the APOC3482C > T variant on insulin, glucose and triglyceride concentrations in different ethnic groups. Diabetologia 44, 245-248. <https://doi.org/10.1007/s001250051607>
165. Weinstein, R. L., Kliman, B., Scully, R. E. (1969) Familial syndrome of primary testicular insufficiency with normal virilization, blindness, deafness and metabolic abnormalities. New Eng. J. Med. 281, 969-977. <https://doi.org/10.1056/NEJM196910302811801>
166. Wen, X. Y., Hegele, R. A., Wang, J., Wang, D. Y., Cheung, J., Wilson, M., Yahyapour, M., Bai, Y., Zhuang, L., Skaug, J., Young, T. K., Connelly, P. W., Koop, B. F., Tsui, L. C., Stewart, A. K. (2003) Identification of a novel lipase gene mutated in lpd mice with hypertriglyceridemia and associated with dyslipidemia in humans. Hum. Mol. Genet. 12, 1131-1143. <https://doi.org/10.1093/hmg/ddg124>
167. Wojciechowski, A. P., Farrall, M., Cullen, P., Wilson, T. M., Bayliss, J. D., Farren, B., Griffin, B. A., Caslakem, M. J., Packard, C. J., Shepherd, J., Thakker, R., Scott, J. (1991) Familial combined hyperlipidaemia linked to the apolipoprotein AI-CII-AIV gene cluster on chromosome 11q23-q24. Nature 349, 161-164. <https://doi.org/10.1038/349161a0>
168. Yagyu, H., Lutz, E. P., Kako, Y., Marks, S., Hu, Y., Choi, S. Y., Bensadoun, A., Goldberg, I. J. (2002) Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity. Possible causes of hypertriglyceridemia and reduced body mass with VLDL receptor deficiency. J. Biol. Chem. 277, 10037-10043. <https://doi.org/10.1074/jbc.M109966200>
169. Yamada, K., Ishiyama-Shigemoto, S., Ichikawa, F., Yuan, X., Koyanagi, A., Koyama, W., Nonaka, K. (1999) Polymorphism in the 5-prime-leader cistron of the beta-2adrenergic receptor gene associated with obesity and type 2 diabetes. J. Clin. Endocr. Metab. 84, 1754-1757.
170. Yamasaki, Y., Watanabe, T. K., Okuno, S., Ono, T., Oga, K., Mizoguchi-Miyakita, A., Goto, Y., Shinomiya, H., Momota, H., Miyao, H., Hayashi, I., Asai, T., Suzuki, M., Harada, Y., Hishigaki, H., Wakitani, S., Takagi, T., Nakamura, Y., Tanigami, A. (2000) Quantitative trait loci for lipid metabolism in the study of OLETF x (OLETF x Fischer 344) backcross rats. Clin. Exp. Pharmacol. Physiol. 27, 881-886. <https://doi.org/10.1046/j.1440-1681.2000.03353.x>
171. Zhu, Y., Jong, M. C., Frazer, K. A., Gong, E., Krauss, R. M., Cheng, J. F., Boffelli, D., Rubin, E. M. (2000) Genomic interval engineering of mice identifies a novel modulator of triglyceride production. Proc. Natl. Acad. Sci. USA 97, 1137-1142. <https://doi.org/10.1073/pnas.97.3.1137>
front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Submissions

Archive